Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma | |
Mohammed Alnaggar; Yan Xu; Jingxia Li; Junyi He; Jibing Chen; Man Li; Qingling Wu; Li Lin; Yingqing Liang; Xiaohua Wang | |
刊名 | Journal for ImmunoTherapy of Cancer |
2019 | |
卷号 | Vol.7 No.1 |
关键词 | Gamma delta (γδ) T cells Immunotherapy Cholangiocarcinoma Clinical trial |
ISSN号 | 2051-1426 |
URL标识 | 查看原文 |
公开日期 | [db:dc_date_available] |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4741816 |
专题 | 湖南大学 |
作者单位 | 1.Biomedical Translational Research Institute and The First Affiliated Hospital,Jinan University,Guangzhou,People’s Republic of China 2.Department of Oncology, Fuda Cancer Hospital, School of Medicine,Jinan University,Guangzhou,People’s Republic of China 3.Department of Biological Treatment Center, Fuda Cancer Hospital, School of Medicine,Jinan University,Guangzhou,People’s Republic of China |
推荐引用方式 GB/T 7714 | Mohammed Alnaggar,Yan Xu,Jingxia Li,et al. Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma[J]. Journal for ImmunoTherapy of Cancer,2019,Vol.7 No.1. |
APA | Mohammed Alnaggar.,Yan Xu.,Jingxia Li.,Junyi He.,Jibing Chen.,...&Zhinan Yin.(2019).Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma.Journal for ImmunoTherapy of Cancer,Vol.7 No.1. |
MLA | Mohammed Alnaggar,et al."Allogenic Vγ9Vδ2 T cell as new potential immunotherapy drug for solid tumor: a case study for cholangiocarcinoma".Journal for ImmunoTherapy of Cancer Vol.7 No.1(2019). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论